Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Clinical trial NCT05071716 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05071716
- Sponsor
- Bausch Health Americas, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-07
- Primary completion
- 2025-09-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.